Literature DB >> 22687512

Molecular epidemiology of Staphylococcus epidermidis clinical isolates from U.S. hospitals.

Rodrigo E Mendes1, Lalitagauri M Deshpande, Andrew J Costello, David J Farrell.   

Abstract

The epidemiology of Staphylococcus epidermidis in U.S. hospitals remains limited. This study aimed to address the genetic backgrounds of linezolid-susceptible and -resistant S. epidermidis strains (isolated in 2010), including cfr-carrying strains. In addition, the antimicrobial susceptibility profiles and linezolid resistance mechanisms among clonal lineages were assessed. A total of 71 S. epidermidis isolates were selected, and linezolid-resistant strains were screened for cfr and mutations in 23S rRNA, L3, and L4. All isolates were subjected to multilocus sequence typing (MLST), and the results were analyzed by eBURST. Overall, 27 sequence types (STs) were detected, and ST5 (21.1%) and ST2 (16.9%) predominated. The majority (62/71; 87.3%) of STs belonged to clonal complex 2 (CC2), which was mostly comprised of subclusters CC2-II (41/62; 66.1%) and CC2-I (21/62; 33.9%). Other STs were grouped within CC23 or CC32 or were singletons. CC2-I strains were more likely to display a methicillin (95.2% versus 33.3 to 70.7%), a linezolid (47.6% versus 0.0 to 7.3%), or a multidrug (81.0% versus 33.3 to 36.6%) resistance phenotype. Among linezolid-resistant isolates, cfr was noted only within CC2 strains, and it was detected equally in the CC2-I (3/10; 30.0%) and CC2-II (1/3; 33.3%) subclusters. 23S rRNA mutations (G2576 [seven strains] and C2534 [one strain]) were observed only among CC2-I (8/10; 80.0%) isolates. Strains showing a G2576 alteration also had M156 (7/7; 100.0%) and/or H146 (6/7; 85.7%) L3 modifications. This study provides an overview of the S. epidermidis clonal distribution and reports higher resistance rates among CC2-I strains. The results show that cfr may be acquired and expressed by both CC2 main subclusters, while 23S rRNA mutations appeared more often within CC2-I strains. Interestingly, these 23S rRNA mutants also had L3 alterations, which may act synergistically or in a compensatory manner to minimize the fitness cost while providing survival advantages under selective pressure.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22687512      PMCID: PMC3421855          DOI: 10.1128/AAC.00279-12

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  31 in total

1.  Improved multilocus sequence typing scheme for Staphylococcus epidermidis.

Authors:  Jonathan C Thomas; Miguel R Vargas; Maria Miragaia; Sharon J Peacock; Gordon L Archer; Mark C Enright
Journal:  J Clin Microbiol       Date:  2006-12-06       Impact factor: 5.948

2.  Inferring a population structure for Staphylococcus epidermidis from multilocus sequence typing data.

Authors:  M Miragaia; J C Thomas; I Couto; M C Enright; H de Lencastre
Journal:  J Bacteriol       Date:  2007-01-12       Impact factor: 3.490

3.  Molecular characterization of methicillin-resistant Staphylococcus epidermidis strains from bacteraemic patients.

Authors:  S Ibrahem; S Salmenlinna; O Lyytikäinen; M Vaara; J Vuopio-Varkila
Journal:  Clin Microbiol Infect       Date:  2008-11       Impact factor: 8.067

4.  Nosocomial infections by Staphylococcus epidermidis: how a commensal bacterium turns into a pathogen.

Authors:  Wilma Ziebuhr; Susanne Hennig; Martin Eckart; Hennes Kränzler; Christoph Batzilla; Svetlana Kozitskaya
Journal:  Int J Antimicrob Agents       Date:  2006-07-07       Impact factor: 5.283

5.  Identification of a plasmid-borne chloramphenicol-florfenicol resistance gene in Staphylococcus sciuri.

Authors:  S Schwarz; C Werckenthin; C Kehrenberg
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

Review 6.  Staphylococcus epidermidis infections.

Authors:  Cuong Vuong; Michael Otto
Journal:  Microbes Infect       Date:  2002-04       Impact factor: 2.700

7.  Comparison of molecular typing methods for characterization of Staphylococcus epidermidis: proposal for clone definition.

Authors:  M Miragaia; J A Carriço; J C Thomas; I Couto; M C Enright; H de Lencastre
Journal:  J Clin Microbiol       Date:  2007-11-07       Impact factor: 5.948

8.  Interplay in the selection of fluoroquinolone resistance and bacterial fitness.

Authors:  Linda L Marcusson; Niels Frimodt-Møller; Diarmaid Hughes
Journal:  PLoS Pathog       Date:  2009-08-07       Impact factor: 6.823

9.  Molecular characterization of Staphylococcus epidermidis strains isolated from a teaching hospital in Shanghai, China.

Authors:  Min Li; Xing Wang; Qian Gao; Yuan Lu
Journal:  J Med Microbiol       Date:  2009-04       Impact factor: 2.472

10.  Acquisition of a natural resistance gene renders a clinical strain of methicillin-resistant Staphylococcus aureus resistant to the synthetic antibiotic linezolid.

Authors:  Seok-Ming Toh; Liqun Xiong; Cesar A Arias; Maria V Villegas; Karen Lolans; John Quinn; Alexander S Mankin
Journal:  Mol Microbiol       Date:  2007-06       Impact factor: 3.501

View more
  37 in total

1.  Mutations in the bacterial ribosomal protein l3 and their association with antibiotic resistance.

Authors:  Rasmus N Klitgaard; Eleni Ntokou; Katrine Nørgaard; Daniel Biltoft; Lykke H Hansen; Nicolai M Trædholm; Jacob Kongsted; Birte Vester
Journal:  Antimicrob Agents Chemother       Date:  2015-04-06       Impact factor: 5.191

2.  Worrisome trend of new multiple mechanisms of linezolid resistance in staphylococcal clones diffused in Italy.

Authors:  Floriana Campanile; Gino Mongelli; Dafne Bongiorno; Chiara Adembri; Milva Ballardini; Marco Falcone; Francesco Menichetti; Antonella Repetto; Carla Sabia; Assunta Sartor; Claudio Scarparo; Carlo Tascini; Mario Venditti; Federica Zoppi; Stefania Stefani
Journal:  J Clin Microbiol       Date:  2013-01-23       Impact factor: 5.948

3.  Molecular Epidemiology of a Vancomycin-Intermediate Heteroresistant Staphylococcus epidermidis Outbreak in a Neonatal Intensive Care Unit.

Authors:  Jasmine Chong; Caroline Quach; Ana C Blanchard; Philippe Guillaume Poliquin; George R Golding; Céline Laferrière; Simon Lévesque
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

4.  Five-Year Summary of In Vitro Activity and Resistance Mechanisms of Linezolid against Clinically Important Gram-Positive Cocci in the United States from the LEADER Surveillance Program (2011 to 2015).

Authors:  Michael A Pfaller; Rodrigo E Mendes; Jennifer M Streit; Patricia A Hogan; Robert K Flamm
Journal:  Antimicrob Agents Chemother       Date:  2017-06-27       Impact factor: 5.191

5.  High-Resolution Typing of Staphylococcus epidermidis Based on Core Genome Multilocus Sequence Typing To Investigate the Hospital Spread of Multidrug-Resistant Clones.

Authors:  Anne Jamet; Julien Guglielmini; Bryan Brancotte; Mathieu Coureuil; Daniel Euphrasie; Julie Meyer; Johanna Roux; Jean-Philippe Barnier; Emmanuelle Bille; Agnès Ferroni; Jean-François Magny; Christine Bôle-Feysot; Alain Charbit; Xavier Nassif; Sylvain Brisse
Journal:  J Clin Microbiol       Date:  2021-02-18       Impact factor: 5.948

Review 6.  Coagulase-negative staphylococci.

Authors:  Karsten Becker; Christine Heilmann; Georg Peters
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

7.  Significance of Staphylococcus epidermidis in Health Care-Associated Infections, from Contaminant to Clinically Relevant Pathogen: This Is a Wake-Up Call!

Authors:  Micael Widerström
Journal:  J Clin Microbiol       Date:  2016-05-11       Impact factor: 5.948

8.  Prevalence, clonality, and pathogenicity of Staphylococcus epidermidis isolates in newborn feces.

Authors:  S Fill Malfertheiner; S Wendt; F Layer; M Weigl; B Seelbach-Göbel; W König; B König
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-05-30       Impact factor: 3.267

9.  Clonal Emergence of Invasive Multidrug-Resistant Staphylococcus epidermidis Deconvoluted via a Combination of Whole-Genome Sequencing and Microbiome Analyses.

Authors:  Xiqi Li; Cesar A Arias; Samuel L Aitken; Jessica Galloway Peña; Diana Panesso; Michael Chang; Lorena Diaz; Rafael Rios; Yazan Numan; Sammi Ghaoui; Sruti DebRoy; Micah M Bhatti; Dawn E Simmons; Isaam Raad; Ray Hachem; Stephanie A Folan; Pranoti Sahasarabhojane; Awdhesh Kalia; Samuel A Shelburne
Journal:  Clin Infect Dis       Date:  2018-07-18       Impact factor: 9.079

10.  Differing lifestyles of Staphylococcus epidermidis as revealed through Bayesian clustering of multilocus sequence types.

Authors:  Jonathan C Thomas; Liangfen Zhang; D Ashley Robinson
Journal:  Infect Genet Evol       Date:  2013-06-29       Impact factor: 3.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.